Image For Activity Cover
Curated Content for EPs: Pulsed Field Ablation
Curated Content for EPs: Pulsed Field Ablation

This bundle includes 5 sessions and 3.75 ACE credits.

Sessions from HRS2023 included in this bundle:
  • 454568 - What's New in Pulsed Field Ablation
  • 452672 - Pulsed Field Ablation: Insights from Preclinical Studies
  • 436412 - Puled Field/Irreversible Electroporation: What's New?
The following episodes of The Beat and The Lead are also included:
  • The Beat Webinar Series - Episode 3: Pulsed Field Ablation - A Shift in Technology?
  • The Lead Podcast Episode 10: A Discussion of Pulsed Field Ablation for the Treatment of Atrial Fibrillation - PULSED AF Pivotal Trial
  • The Lead Podcast Episode 48: Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation
Learning Objectives
  • Summarize the basics of pulsed-field ablation
  • Interpret new clinical findings of pulsed-field ablation
  • Compare the characteristics of lesions using the different ablation technologies (RF, Cryo, and PF) 
Target Audience
This activity is designed for Physicians, Advanced Practice Providers, and other Allied Professionals in the Field of EP.
Faculty and Faculty Disclosures
Amim Al-Ahmad, MD, FHRS, CCDS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott Medical, BioSense Webster, Inc., MediaSphere Medical, Medtelligence, BioSig Technologies, Toray, Haemonetics, Philips, E-safe, Shifamed, SoundCath

Equity in E-safe, SoundCath, Encompass Vascular, Myra Vision, Supira Medical, Tioga Cardiovascular, Akura Medical

Thomas Dewland:
Honoraria/Speaking/Consulting Fee: Adagio Medical 

Luigi Di Biase:
Honoraria/Speaking/Consulting Fee: Baylis Medical Company (Honoraria/Speaking/Consulting Fee), Biosense Webster, Inc., Abbott, Boston Scientific, Medtronic, Biotronik, Rhythm Management Group Corp, Zoll Medical Corporation 

Edward Gerstenfeld:
Honoraria/Speaking/Consulting Fee: Medtronic, Boston Scientific, Biosense Webster, Inc., Abbott, Thermedical 

Melanie Gunawardene, MD
Honoraria, Speaking/Consulting Fee: Farapulse, Abbott Medical

Fellowship Support: Boston Scientific
Travel: Biosense Webster, Inc.

Satoshi Higuchi
Nothing Relevant to Disclose 

Philippa Hill
Nothing Relevant to Disclose 

Ayman Hussein
Research (Contracted Grants for PIs and Named Investigators only): Boston Scientific

Atsushi Ikeda
Nothing Relevant to Disclose 

Michael S. Lloyd, MD, FHRS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott Medical, Balis Medical Company

Sanghamitra Mohanty
Nothing Relevant to Disclose 

Jacopo Marazzato
Nothing Relevant to Disclose 

Hiroshi Nakagawa:
Honoraria/Speaking/Consulting Fee:Biosense Webster, Inc., Affera, Inc., Fukuda-Denshi, Japan Lifeline, Stereotaxis, Inc, Acutus Medical Inc, Galaxy Medical, Inc

Shady Nakhla
Nothing Relevant to Disclose 

Andrea Natale, MD, FHRS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott Medical, BioSense Webster Inc., Baylis Medical Company, Biotronik

Jonathan Piccini:
Research Contracted Grants for PIs and Named Investigators only: Boston Scientific , Bayer Healthcare Pharmaceuticals, Abbott, Philips, Element Science, Inc, iRhythm Technologies,
Honoraria/Speaking/Consulting Fee: Abbott, Medtronic, Philips, LivaNova, Sanofi, Biotronik, AbbVie, ARCA Biopharma Inc. Bristol-Myers Squibb Boston Scientific ElectroPhysiology Frontiers, Itamar Medical, UpToDate, Inc.,

Walid Saliba:
Honoraria/Speaking/Consulting Fee: Boston Scientific, AtriCure, Inc., Cardiva Medical, Inc.

Javier Sanchez, MD

Nothing to disclose.

Prashanthan Sanders, MBBS, PhD, FHRS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott Medical

Research: Medtronic, Boston Scientific, Abbott Medical CathRx, Pacemate, MicroPort Scientific Corporation, Becton Dickinson, EBR Systems

Pasquale Santangeli
Honoraria/Speaking/Consulting Fee: Abbott, Biosense Webster, Inc., Medtronic, Asahi Medical

Research (Contracted Grants for PIs and Named Investigators only): Biosense Webster, Inc.

William H. Sauer, MD, FHRS, CCDS
Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific

Research: Medtronic

Oussama Wazni:
Honoraria/Speaking/Consulting Fee: Boston Scientific, Biosense Webster, Inc.

Boris Schmidt, MD, FHRS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbot, Bionsense Webster Inc., CardioFocus Inc.

Research: Farapulse

Nathaniel Steiger, MD
Nothing to disclose.

Masafumi Sugawara
Nothing Relevant to Disclose 

Kamala Tamirisa, MD, FHRS
Honoraria, Speaking/Consulting Fee: Medscape, Abbott Medical

Paul C Zei, MD, PhD, FHRS
Honoraria/Speaking/Consulting: Varian Medical Systems, Biosense Webster, Inc., Abbott

Research: Biosense Webster, Inc.
Stocks, Publicly Traded: Affera, Inc.

 Fengwei Zou
Nothing Relevant to Disclose 

Disclosure Policy

Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.


Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.

ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

  • Advertising, marketing, or communication firms whose clients are ineligible companies
  • Bio-medical startups that have begun a governmental regulatory approval process
  • Compounding pharmacies that manufacture proprietary compounds
  • Device manufacturers or distributors
  • Diagnostic labs that sell proprietary products
  • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
  • Manufacturers of health-related wearable products
  • Pharmaceutical companies or distributors
  • Pharmacy benefit managers
  • Reagent manufacturers or sellers


All relevant financial relationships have been mitigated.

ACE Statements
Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Availability: On-Demand
Cost: Member: $49.00
Non-Member: $59.00
Credit Offered:
3.75 ACE Credits
3.75 COP Credits
3.75 ABIM-MOC Points
3.75 ABP-MOC Points
Contains: 7 Courses
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
Android App Download IOS App Download Powered By